​

Definium Therapeutics Ownership | Who Owns Definium Therapeutics?


OverviewForecastFinancialsChartTranscripts

Definium Therapeutics Ownership Summary


Definium Therapeutics is owned by 106.41% institutional investors, 1.73% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.64% of DFTX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.63% of its assets in Definium Therapeutics shares.

DFTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDefinium Therapeutics106.41%1.73%-8.13%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de11.77M10.64%$448.06M
Fmr9.08M8.21%$345.67M
Capital world investors8.26M7.46%$314.21M
Avoro capital advisors7.19M6.61%$338.17M
Driehaus capital management6.85M6.29%$322.00M
Price t rowe associates inc /md/4.65M4.28%$218.83M
Geode capital management3.64M3.29%$138.75M
State street3.30M2.98%$125.64M
Octagon capital advisors lp2.95M2.71%$138.77M
Wellington management group llp2.95M2.71%$138.76M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Octagon capital advisors lp2.95M12.47%$138.77M
Data collective iv gp100.35K6.01%$4.72M
Commodore capital lp2.00M5.60%$94.08M
Superstring capital management lp188.28K5.59%$8.86M
Catalio capital management, lp562.67K4.97%$26.47M
Great point partners425.00K3.78%$19.99M
Boxer capital management998.50K3.54%$46.97M
Avoro capital advisors7.19M3.04%$338.17M
Awm investment company764.80K2.80%$29.11M
Patient square capital lp385.00K2.34%$14.65M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/4.65M0.02%4.58M
Fmr9.08M0.01%4.33M
Capital world investors8.26M0.04%2.89M
Avoro capital advisors7.19M3.04%2.19M
Alliancebernstein1.80M0.01%1.71M

Top Sellers

HolderShares% AssetsChange
Siren---1.42M
Sixth street partners management company---1.08M
Arrowmark colorado564.07K1.10%-1.03M
Marshall wace, llp491.03K0.02%-807.92K
Millennium management266.08K0.00%-580.82K

New Positions

HolderShares% AssetsChangeValue
Ra capital management1.50M0.61%1.50M$70.56M
Lord, abbett958.63K0.11%958.63K$36.49M
Polar capital777.25K0.09%777.25K$36.56M
Bamco inc /ny/520.11K0.04%520.11K$24.47M
Great point partners425.00K3.78%425.00K$19.99M

Sold Out

HolderChange
Corecap advisors-5.00
Gilpin wealth management-6.00
Comprehensive financial planning, inc./pa-8.00
Ares financial consulting-8.00
Covestor-27.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202638447.69%115,759,80848.34%1062.07%2689.39%661550.00%
Mar 31, 20262533062.50%73,974,924557.41%8252.19%2382875.00%4-
Dec 31, 20258-11,252,538-12-8---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A10.25M7.63%2.56M
iShares Russell 2000 ETF3.17M2.36%-
Vanguard Institutional Extnd Mkt Idx Tr1.49M1.11%7.68K
Fidelity Small Cap Index1.42M1.06%2.03K
Vanguard Health Care Inv1.27M0.94%527.23K
iShares Russell 2000 Growth ETF1.18M0.88%-4.46K
US Small-Cap Growth II Equity Comp1.14M0.86%1.14M
T. Rowe Price New Horizons1.13M0.84%-85.50K
iShares Biotechnology ETF996.28K0.74%-4.93K
T. Rowe Price Integrated US Sm Gr Eq901.49K0.67%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 25, 2026Karlin Daniel Chief Medical OfficerSell$396.89K
Sep 25, 2026Barrow Robert Chief Executive OfficerSell$1.15M
Sep 25, 2026Wiley Matthew T. Chief Commercial OfficerSell$113.26K
Sep 25, 2026Sullivan Mark Chief Legal OfficerSell$513.85K
Sep 25, 2026Roberts Brandi Chief Financial OfficerSell$123.50K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-5
2026 Q1-3

DFTX Ownership FAQ


Who Owns Definium Therapeutics?

Definium Therapeutics shareholders are primarily institutional investors at 106.41%, followed by 1.73% insiders and -8.14% retail investors. The average institutional ownership in Definium Therapeutics's industry, Biotech Stocks , is 385.89%, which Definium Therapeutics falls below.

Who owns the most shares of Definium Therapeutics?

Definium Therapeutics’s largest shareholders are Blackrock funding, inc. /de (11.77M shares, 10.64%), Fmr (9.08M shares, 8.21%), and Capital world investors (8.26M shares, 7.46%). Together, they hold 26.30% of Definium Therapeutics’s total shares outstanding.

Does Blackrock own Definium Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Definium Therapeutics.

Who is Definium Therapeutics’s biggest shareholder by percentage of total assets invested?

Octagon capital advisors lp is Definium Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.47% of its assets in 2.95M Definium Therapeutics shares, valued at 138.77M$.

Who is the top mutual fund holder of Definium Therapeutics shares?

American Funds SMALLCAP World A is the top mutual fund holder of Definium Therapeutics shares, with 7.63% of its total shares outstanding invested in 10.25M Definium Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools